Lymphoma | RTP Live from Chicago: Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma

Research To Practice | Oncology Videos · Jul 12, 2024 · 1h

Featuring perspectives from Dr Joshua Brody, Dr Ian W Flinn and Dr Tycel Phillips, including the following topics:

Introduction: CD3 Bispecific Antibodies in the Community Oncology Setting (0:00)

Integration of Bispecific Antibody Therapy into the Management of Diffuse Large B-Cell Lymphoma — Dr Phillips (18:13)

Current and Future Role of Bispecific Antibodies in Follicular Lymphoma and Other B-Cell Lymphomas — Dr Flinn (41:20)

Tolerability and Other Practical Considerations with the Use of Bispecific Antibody Therapy — Dr Brody(50:49)

CME information and select publications